KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Brinks (BCO) Asset Writedowns and Impairment (2016 - 2025)

Brinks (BCO) has disclosed Asset Writedowns and Impairment for 17 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 120.0% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.7 million, a 81.25% increase, with the full-year FY2025 number at $8.7 million, up 81.25% from a year prior.
  • Asset Writedowns and Impairment was $3.3 million for Q4 2025 at Brinks, down from $3.4 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $5.0 million in Q3 2021 to a low of $400000.0 in Q2 2025.
  • A 5-year average of $2.1 million and a median of $1.5 million in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: plummeted 86.49% in 2024, then soared 220.0% in 2025.
  • Brinks' Asset Writedowns and Impairment stood at $2.0 million in 2021, then plummeted by 45.0% to $1.1 million in 2022, then skyrocketed by 90.91% to $2.1 million in 2023, then dropped by 28.57% to $1.5 million in 2024, then skyrocketed by 120.0% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for BCO's Asset Writedowns and Impairment are $3.3 million (Q4 2025), $3.4 million (Q3 2025), and $400000.0 (Q2 2025).